Tech Company Financing Transactions

Arthrosi Therapeutics Funding Round

Arthrosi Therapeutics, operating out of San Diego, received $75 million in investment from Guangrun Health Industry and Reichstein Biotech.

Transaction Overview

Announced On
7/12/2023
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series D
Proceeds Purpose
The company intends to use the funds for the development of AR882, a URAT1 inhibitor.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9855 Towne Centre Dr 200
San Diego, CA 92121
USA
Email Address
Overview
Arthrosi Therapeutics, Inc. was founded in San Diego, CA, in 2018, by a world-class team of gout experts who spearheaded the clinical development of the first generation of urate inhibitor treatment for gout at Ardea Biosciences resulting in a $1.26 Billion acquisition by AstraZeneca. With its vast therapeutic and treatment knowledge, Arthrosi has efficiently completed multiple robust phase 1 and 2 clinical studies in a mere two years and accumulated a comprehensive and robust intellectual property portfolio.
Profile
Arthrosi Therapeutics LinkedIn Company Profile
Social Media
Arthrosi Therapeutics Company Twitter Account
Company News
Arthrosi Therapeutics News
Facebook
Arthrosi Therapeutics on Facebook
YouTube
Arthrosi Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Litain Yeh
  Litain  Yeh LinkedIn Profile  Litain  Yeh Twitter Account  Litain  Yeh News  Litain  Yeh on Facebook
Chief Medical Officer
Robert Keenan
  Robert Keenan LinkedIn Profile  Robert Keenan Twitter Account  Robert Keenan News  Robert Keenan on Facebook
Chief Operating Officer
Shunqi Yan
  Shunqi Yan LinkedIn Profile  Shunqi Yan Twitter Account  Shunqi Yan News  Shunqi Yan on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/12/2023: Oritain venture capital transaction
Next: 7/12/2023: Eureka Health venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary